Quick Answer
Compounded tirzepatide costs $299 to $549 per month in 2026 through US-licensed telehealth providers, depending on the provider, the dose, and the commitment tier, with the physician consultation, medication, and shipping typically bundled.
Compounded preparations are not FDA-approved as final products and are not generic versions of, or interchangeable with, any brand-name medication. The active pharmaceutical ingredient meets United States Pharmacopeia (USP) standards. The pricing reflects production and program cost at accredited pharmacies, not lower quality.
2026 Compounded Tirzepatide Pricing (Real Numbers)
Pricing verified June 2026 against each provider's published pricing page. Re-verify quarterly; telehealth pricing changes often. All prices reflect cash pricing without insurance, in USD.
| Provider | Plan | First month | Ongoing | All-inclusive? |
|---|---|---|---|---|
| Majesta Health | Performance (tirzepatide injection) | $339 | $439/month | Yes (physician, medication, shipping, messaging) |
| Henry Meds | Compounded tirzepatide | $369 to $499/month | Same | Multiple commitment tiers |
| Medvi | Compounded tirzepatide injection | $329 | $429/month | Single plan structure |
| Mochi Health | Compounded tirzepatide + coaching | $79 membership + medication | Varies by dose | Membership plus medication structure |
2026 market shift you should know about. Hims & Hers and Ro, two of the largest telehealth names, both adjusted their compounded GLP-1 offerings in 2025-2026 and moved away from compounded tirzepatide. Ro now sells brand-name only. That leaves compounded tirzepatide to focused providers like Majesta Health, Henry Meds, Medvi, and Mochi. If you see an older article listing Hims or Ro compounded tirzepatide pricing, it is out of date.
For a broader walkthrough of buying compounded tirzepatide online, see our compounded tirzepatide online in 2026 guide.
Brand-Name Pricing, for Reference
Brand-name tirzepatide is a separate, FDA-approved category. For consumer reference, here are the published cash prices as of June 2026 (manufacturer list prices; verify current figures with the manufacturer):
| Brand | Manufacturer | Cash price per month | Indication |
|---|---|---|---|
| Zepbound (pens) | Eli Lilly | ~$1,086 | FDA-approved for chronic weight management and (since 2024) moderate-to-severe obstructive sleep apnea in adults with obesity |
| Zepbound (vials, LillyDirect self-pay) | Eli Lilly | ~$349 to $499 | Same indication; lower-cost self-pay vials sold direct |
| Mounjaro | Eli Lilly | ~$968 to $1,150 | FDA-approved for type 2 diabetes; often prescribed off-label for weight management |
Eli Lilly's LillyDirect self-pay vials brought brand-name tirzepatide pricing down meaningfully for cash-paying patients, and with commercial insurance coverage, copays for brand-name tirzepatide can be as low as $25 to $100 per month when approved, which often requires prior authorization with documented BMI and comorbidity criteria.
Whichever routes are open to you, compare the documented all-in monthly totals rather than headline prices.
For more on the medication itself, see our guide to compounded tirzepatide online in 2026.
What the Price Should Include
The headline price is only meaningful if you know what is bundled. A $199 plan that bills consultation, shipping, and refills separately can easily cost more than a $329 plan with everything included.
A legitimate $299 to $549 monthly compounded tirzepatide plan in 2026 should include:
- The compounded tirzepatide medication itself, prepared by a state-licensed compounding pharmacy
- Physician consultation with a US-licensed doctor (any medical consultation fee should be disclosed upfront)
- Discreet shipping in plain packaging
- Unlimited messaging or scheduled check-ins with your physician for dose adjustments and side-effect questions
- Ongoing dose adjustments through your titration phase
- The ability to cancel anytime without forfeiting a prepayment
What should NOT be hidden in the fine print:
- Separate consultation, lab, refill, or visit fees
- A required multi-month prepay to access the published price
- A required paid coaching tier bundled with the medication
- Dose-escalation upcharges (you should pay the same price across the titration range)
What Drives Compounded Pricing
Compounded tirzepatide contains an active pharmaceutical ingredient that meets United States Pharmacopeia (USP) standards. It is not FDA-approved as a final product and is not a generic version of, or interchangeable with, any brand product. Three things shape how compounded pricing is set:
- No trial recovery cost. The brand price helps recover the cost of the SURMOUNT and SURPASS clinical programs and the FDA approval pathway. Compounded preparations do not carry that.
- Smaller-batch production. State-licensed 503A and 503B pharmacies compound in smaller batches rather than running global industrial manufacturing lines.
- No mass marketing premium. A large share of brand cost is sales and advertising. Compounded pricing does not include that.
The trade-off is real and worth stating plainly: compounded preparations are not FDA-approved as final products. The active ingredient meets United States Pharmacopeia (USP) standards, and accredited pharmacies batch-test every preparation, but the specific compounded formulation has not been reviewed by the FDA the way the brand product has.
Insurance and HSA / FSA Reality (2026)
Commercial insurance almost never covers compounded tirzepatide. Coverage for brand-name (Zepbound or Mounjaro) is variable. Most weight-management-indication coverage requires prior authorization with documented BMI plus comorbidity criteria. Coverage for Mounjaro for diabetes is generally broader than coverage for weight management.
Medicare does not cover GLP-1 and GIP medications for weight loss as of 2026. Medicare Part D covers Mounjaro for the diabetes indication.
Medicaid varies by state. Many state programs cover these medications for diabetes only.
HSA and FSA cards typically reimburse prescription compounded tirzepatide when accompanied by valid documentation. Save your prescription confirmation and pharmacy receipts.
Dose and Price: How Titration Works
Tirzepatide is not a fixed dose. It steps up over time:
- Most patients start at 2.5 mg per week for the first month
- The dose increases in steps (commonly to 5 mg, then higher) as tolerated
- The maintenance range sits higher than the starting dose
At a fair provider, the monthly price stays the same across this titration range. You should not pay more simply because your dose increased on schedule. If a provider's price climbs every time your dose goes up, that is a dose-escalation upcharge, and it can quietly turn a $299 headline into a much higher real cost at maintenance.
The Majesta Performance plan holds one price across the titration phase, so the number you see in month one is the number you plan around.
Hidden Fees to Watch For
The published headline is not the real cost if any of these are billed on the side:
- Separate consultation fees charged on top of the plan
- Shipping fees per order
- Refill or visit fees at each renewal
- Lab work fees required before the first fill
- Multi-month prepay required to unlock the lowest advertised price
- Cancellation penalties if you stop early
- Paid coaching tiers bundled in whether you want them or not
- Dose-escalation upcharges as your titration moves up
The honest way to compare two providers is to add up the total first-month cost including any one-time fees, then the total ongoing monthly cost with no commitment. Compare those two numbers, not the marketing headline.
How Majesta Performance Prices It
The Majesta Health Performance plan is compounded tirzepatide injection at a flat, all-in price:
- $339 your first month
- $439 per month after that
- One price held across the titration range (no dose-escalation upcharge)
- Includes the physician consultation, the compounded medication, discreet shipping, and ongoing physician messaging
Here is the all-in six-month math, which is the comparison that matters for cash-paying patients:
| Plan | Month 1 | Months 2-6 | Total six-month | Average / month |
|---|---|---|---|---|
| Majesta Performance (tirzepatide) | $339 | $439 × 5 = $2,195 | $2,534 | $422 |
| Other compounded providers (mid-tier $449/mo) | $449 | $449 × 5 = $2,245 | $2,694 | $449 |
Totals assume monthly billing; see each provider's billing policy for cycle details. This table compares compounded telehealth programs only; brand-name pricing is published by the manufacturers and depends on coverage.
Why Pricing Should Not Be the Only Factor
Three factors matter as much as price when evaluating any compounded tirzepatide source:
- Is the prescribing physician real and US-licensed? Cheap sources often skip this. Skipping medical screening is the actual safety risk.
- Is the dispensing pharmacy accredited? A 503A or 503B pharmacy with NABP accreditation and LegitScript certification, that batch-tests every preparation for potency and sterility, operates at a much higher safety standard than an unaccredited one.
- Is ongoing physician access included? Side effects and dose adjustments happen for almost every patient in the first 2 to 3 months. Without a physician you can message, you handle them alone.
In the SURMOUNT-1 trial, published results reported meaningful average weight reduction over 72 weeks at the studied doses (published trial data). That is brand-product trial data, and individual results may vary. No legitimate provider, including Majesta, can promise a specific outcome for you.
The Bottom Line
In 2026, compounded tirzepatide costs $299 to $549 per month through US-licensed telehealth providers, all-in. Brand-name routes have their own pricing, published by the manufacturer, and with insurance coverage brand-name copays can win on math, though coverage for weight management is patchy and often requires prior authorization. Compare documented totals for your own situation.
Compounded preparations are not FDA-approved as final products; the active pharmaceutical ingredient meets United States Pharmacopeia (USP) standards.
The number that matters is not the headline. It is the all-in monthly cost at a provider with a real US-licensed physician, an accredited compounding pharmacy, one price across your titration range, and ongoing physician access included.
If you want a physician-reviewed recommendation specific to your situation, start your 2-minute medical assessment at /quiz. A US-licensed physician will review your information, screen for contraindications, and confirm the right plan for you.
Related guides
- Compounded tirzepatide online in 2026: the legitimate path
- Cheapest tirzepatide online: safe and affordable options in 2026
- Compounded semaglutide cost in 2026: the honest breakdown
- Tirzepatide vs semaglutide: the honest 2026 comparison
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Prices reflect typical 2026 US retail and are subject to change. Individual results may vary.
Frequently Asked Questions
How much does compounded tirzepatide cost per month in 2026?
Through US-licensed telehealth providers, compounded tirzepatide costs $299 to $549 per month in 2026, depending on the provider, the dose, and the commitment tier, with the physician consultation, medication, and shipping typically bundled. Brand-name prices and insurance coverage vary widely; current brand pricing is published by the manufacturers. Compounded preparations are not FDA-approved as final products and are not generic versions of, or interchangeable with, any brand-name medication.
Why is compounded tirzepatide priced the way it is?
Compounded tirzepatide contains an active pharmaceutical ingredient that meets United States Pharmacopeia (USP) standards, prepared in small, patient-specific batches at state-licensed 503A or 503B compounding pharmacies. The monthly price reflects ingredient and preparation cost plus the bundled physician consultation and shipping, set by each provider. It is a separate category from FDA-approved brand medications, whose prices are set by the manufacturers and depend on coverage. The trade-off is that the compounded preparation itself is not FDA-approved as a final product and is not a generic version of, or interchangeable with, any brand product.
Does compounded tirzepatide cost more as the dose goes up?
At a legitimate provider, no. Tirzepatide titrates from a low starting dose (commonly 2.5 mg per week) up through a maintenance range over several months. A fair plan charges the same monthly price across the titration range. If a provider charges more each time your dose increases, that is a dose-escalation upcharge to watch for. The Majesta Performance plan holds one price across the titration phase.
Does insurance cover compounded tirzepatide?
Compounded tirzepatide is almost never covered by commercial insurance, Medicare, or Medicaid; it is a cash-pay program with one bundled monthly price. HSA and FSA cards are typically accepted by US-licensed telehealth providers with a valid prescription. If insurance covers brand-name Zepbound at a low copay, the covered brand route can win on math. Compare your documented out-of-pocket cost on any covered option against the all-in compounded cash price.
Can I use my HSA or FSA card for compounded tirzepatide?
In most cases, yes. HSA and FSA cards typically reimburse prescription compounded tirzepatide when accompanied by valid documentation. Save your prescription confirmation and pharmacy receipts in case your plan administrator asks for them. Most US-licensed telehealth providers accept HSA and FSA cards at checkout the same way they accept a regular debit or credit card.
What hidden fees should I watch for when comparing compounded tirzepatide prices?
Watch for separate consultation fees, shipping fees, refill fees, lab work fees, multi-month prepay requirements to access the published cheapest tier, plan cancellation penalties, paid coaching tiers bundled with the medication, and undisclosed dose-escalation upcharges. The fair way to compare providers is to compute the total first-month cost including any one-time fees, and the total ongoing monthly cost with no commitment.
Majesta Health medical content is written against primary sources (FDA labels, peer-reviewed trials, HHS and CDC publications) and passes a documented compliance review before publication. We are rolling out named physician review with US-licensed clinicians from our partner MD Integrations (MDI): each reviewed article will show the reviewing physician's name, NPI, and review date. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across the states we currently serve through the MD Integrations Medical Services Organization (coverage varies by state; see our states page)
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited); Majesta prescriptions are dispensed through Belmar's state-licensed 503A compounding pharmacy